• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [24117 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2023     Agency for Healthcare Research and Quality (AHRQ) Pharmacologic and nonpharmacologic treatments for posttraumatic stress disorder: an update of the PTSD repository evidence base
2003     Agency for Healthcare Research and Quality (AHRQ) Pharmacologic management of heart failure and left ventricular systolic dysfunction: effect in female, black, and diabetic patients, and cost-effectiveness
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacologic smoking cessation interventions for patients with cardiovascular conditions: a review of the safety and guidelines
2014     Agency for Healthcare Research and Quality (AHRQ) Pharmacologic therapies for the management of crohn's disease: comparative effectiveness
2014     Agency for Healthcare Research and Quality (AHRQ) Pharmacologic therapies for the management of Crohn's disease: comparative effectiveness
2005     HAYES, Inc. Pharmacologic treatment of sleep apnea
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacologic-based strategies for smoking cessation
2018     NIHR Health Technology Assessment programme Pharmacological and non-pharmacological interventions for non-respiratory sleep disturbance in children with neurodisabilities: a systematic review
2018     NIHR Health Technology Assessment programme Pharmacological and non-pharmacological interventions for non-respiratory sleep disturbances in children with neurodevelopmental disorders: a systematic review
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacological and non-pharmacological therapies for adults with attention-deficit/hyperactivity disorder: systematic review and meta-analysis of clinical evidence
2004     Agency for Healthcare Research and Quality (AHRQ) Pharmacological and surgical treatment of obesity
2006     Belgian Health Care Knowledge Centre (KCE) Pharmacological and surgical treatment of obesity. Residential care for severely obese children in Belgium
2003     Institute for Clinical Systems Improvement (ICSI) Pharmacological approaches to weight loss in adults
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacological interventions for weight loss: a review of the clinical and cost-effectiveness
2009     Canadian Agency for Drugs and Technologies in Health (CADTH) Pharmacological management of depression in Parkinson's disease: evidence for antidepressant of choice
2004     Agency for Healthcare Research and Quality (AHRQ) Pharmacological treatment of dementia
2014     Agency for Healthcare Research and Quality (AHRQ) Pharmacotherapy for adults with alcohol-use disorders in outpatient settings
1999     Agency for Healthcare Research and Quality (AHRQ) Pharmacotherapy for alcohol dependence
2012     National Institute for Health and Care Excellence (NICE) Pharmalgen for the treatment of bee and wasp venom allergy. NICE technology appraisal guidance 246
2024     National Institute for Health and Care Excellence (NICE) Pharyngeal electrical stimulation for neurogenic dysphagia. NICE interventional procedures guidance 781
2007     Health Technology Assessment Section, Ministry of Health Malaysia (MaHTAS) PhaSeal System for Chemopreparation
2011     NIHR Horizon Scanning Centre (NIHR HSC) Phentermine/topiramate (Qnexa) for weight loss and maintenance of weight loss
2013     HAYES, Inc. Phenylalanine hydroxylase (PAH) deficiency (including phenylketonuria [PKU])
2010     Canadian Agency for Drugs and Technologies in Health (CADTH) Phosphodiesterase 5 inhibitors: a review of the clinical effectiveness and cost-effectiveness
2021     Canadian Agency for Drugs and Technologies in Health (CADTH) Phosphodiesterase type-5 inhibitors for the treatment of secondary Raynaud's phenomenon and digital ulcers
2006     NIHR Horizon Scanning Centre (NIHR HSC) Photo-activated disinfection for tooth decay: horizon scanning technology note
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Photo-activated disinfection therapy for dental surgery: review of the clinical effectiveness
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Photo-activated disinfection therapy for non-dental surgery: review of the clinical effectiveness
2022     Health Technology Wales (HTW) Photobiomodulation for the prevention and treatment of oral mucositis and radiation dermatitis associated with cancer treatment
2013     National Institute for Health and Care Excellence (NICE) Photochemical corneal collagen cross-linkage using riboflavin and ultraviolet A for keratoconus and keratectasia. NICE interventional procedures guidance 466
2004     National Institute for Health and Care Excellence (NICE) Photodynamic endometrial ablation. NICE interventional procedures guidance 47
2001     Wessex Institute for Health Research and Development (WIHRD) Photodynamic phototherapy (including verteporfin) for neovascular age related macular degeneration
2009     Health Technology and Policy Unit (HTPU) Photodynamic therapy for the treatment of barrett's esophagus: a systematic review and economic evaluation
1994     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Photodynamic therapy - Summary
1999     ECRI Photodynamic therapy [PDT] for chest wall recurrence and metastatic cutaneous breast cancer
2004     HAYES, Inc. Photodynamic therapy for actinic keratoses
2010     HAYES, Inc. Photodynamic therapy for actinic keratosis and squamous cell carcinoma in situ
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Photodynamic therapy for actinic keratosis treatment
2004     National Institute for Health and Care Excellence (NICE) Photodynamic therapy for advanced bronchial carcinoma. NICE interventional procedures guidance 87
2000     Norwegian Knowledge Centre for the Health Services (NOKC) Photodynamic therapy for age-related macular degeneration
2001     HAYES, Inc. Photodynamic therapy for Barrett's oesophagus and oesophageal cancer
2010     National Institute for Health and Care Excellence (NICE) Photodynamic therapy for Barrett's oesophagus. NICE interventional procedures guidance 350
2005     National Institute for Health and Care Excellence (NICE) Photodynamic therapy for bile duct cancer. NICE interventional procedures guidance 134
2009     National Institute for Health and Care Excellence (NICE) Photodynamic therapy for brain tumours. NICE interventional procedures guidance 290
2013     Malaysian Health Technology Assessment (MaHTAS) Photodynamic therapy for cancer treatment – an update
2006     National Institute for Health and Care Excellence (NICE) Photodynamic therapy for early-stage oesophageal cancer. NICE interventional procedures guidance 200
2013     HAYES, Inc. Photodynamic therapy for head and neck cancer
2002     Institute for Clinical Systems Improvement (ICSI) Photodynamic therapy for head and neck, tracheobronchial, and esophageal cancer
2005     National Institute for Health and Care Excellence (NICE) Photodynamic therapy for localised inoperable endobronchial cancer. NICE interventional procedures guidance 137
2001     Medical Services Advisory Committee (MSAC) Photodynamic therapy for macular degeneration (additional indications) (#1039)
2006     National Institute for Health and Care Excellence (NICE) Photodynamic therapy for non-melanoma skin tumours (including premalignant and primary non-metastatic skin lesions). NICE interventional procedures guidance 155
2010     HAYES, Inc. Photodynamic therapy for nonmelanoma skin cancer
1999     Medical Services Advisory Committee (MSAC) Photodynamic therapy for skin and mucosal cancer
2001     The Swedish Council on Health Technology Assessment (SBU) Photodynamic therapy for skin cancer - early assessment briefs (Alert)
2011     Health Technology and Policy Unit (HTPU) Photodynamic therapy for skin cancer & pre-cancerous skin conditions
2009     Health Technology and Policy Unit (HTPU) Photodynamic therapy for the treatment of early esophageal cancer: a systematic review and economic evaluation
2007     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Photodynamic therapy for the treatment of malignant stenosis in the alimentary tract
2021     Agency for Care Effectiveness (ACE) Photodynamic therapy for treating non-melanoma skin tumours
1999     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Photodynamic therapy in gastroenterology and ENT (systematic review, expert panel)
2002     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Photodynamic therapy in the treatment of age-related macular degeneration
2006     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Photodynamic therapy in the treatment of age-related macular degeneration (update)
2002     HAYES, Inc. Photodynamic therapy with verteporfin (visudyne) for neovascular age-related macular degeneration
2001     Medical Services Advisory Committee (MSAC) Photodynamic therapy with verteporfin for age related macular degeneration
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Photodynamic therapy with verteporfin for the treatment of neovascular age-related macular degeneration: a clinical assessment
2009     HAYES, Inc. Photodynamic therapy with visudyne (verteporfin) (QLT Inc.) for central serous retinopathy (CSR)
2009     HAYES, Inc. Photodynamic therapy with visudyne (verteporfin) (QLT Inc.) for choroidal hemangioma
2009     HAYES, Inc. Photodynamic therapy with visudyne (verteporfin) (QLT Inc.) for idiopathic subfoveal choroidal neovascularization (CNV)
2003     Adelaide Health Technology Assessment (AHTA) Photodynamic therapy: improving survival and quality of life for patients with non-resectable cholangiocarcinoma
2001     The Swedish Council on Health Technology Assessment (SBU) Photodynamic treatment for macular degeneration - early assessment briefs (ALERT)
1996     Healthcare Insurance Board/ College Voor Zorgverzekeringen (CVZ) Photodynamic treatment of non-small-cell lung cancer - primary research
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Photofrin (R)
2011     HAYES, Inc. Photographic surveillance for early detection of malignant melanoma
2001     HAYES, Inc. Photographic surveillance for early detection of malignant melanoma
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Photon radiosurgery system
2002     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Photonic stimulation for the treatment of chronic pain
2006     National Institute for Health and Care Excellence (NICE) Photorefractive (laser) surgery for the correction of refractive errors. NICE interventional procedures guidance 164
2013     HAYES, Inc. Photoscreening for the detection of amblyopia risk factors in children
2009     Health Services Assessment Collaboration (HSAC) Photoselective vaporisation for benign prostatic hyperplasia: a rapid literature scan
2007     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Photoselective vaporisation of the prostate in men with benign prostatic hyperplasia
2006     Canadian Agency for Drugs and Technologies in Health (CADTH) Photoselective vaporization for benign prostatic hyperplasia
2013     Health Quality Ontario (HQO) Photoselective vaporization for the treatment of benign prostatic hyperplasia
2007     Health Technology and Policy Unit (HTPU) Photoselective vaporization of the prostate (PVP) for the treatment of benign prostatic hyperplasia (BPH)
1996     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) Phototherapeutic keratectomy with excimer laser
2010     National Institute for Health and Care Excellence (NICE) Phototherapeutic laser keratectomy for corneal surface irregularities. NICE interventional procedures guidance 358
2007     HAYES, Inc. Phototherapy blankets versus standard phototherapy lights for the treatment of neonatal hyperbilirubinemia
2009     HAYES, Inc. Phototherapy for acne vulgaris
2005     HAYES, Inc. Phototherapy for acne vulgaris
2012     HAYES, Inc. Phototherapy for early-stage mycosis fungoides
2003     Centre for Clinical Effectiveness (CCE) Phototherapy in the home for jaundiced neonates
2024     National Institute for Health and Care Excellence (NICE) Phrenic nerve pacing for congenital central hypoventilation syndrome. NICE interventional procedures guidance 790
2024     National Institute for Health and Care Excellence (NICE) Phrenic nerve pacing for ventilator-dependent high cervical spinal cord injury. NICE interventional procedures guidance 792
1999     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Phrenic nerve stimulator
2013     National Institute for Health and Care Excellence (NICE) Phrenic nerve transfer in brachial plexus injury. NICE interventional procedures guidance 468
2021     Agency for Healthcare Research and Quality (AHRQ) Physical activity and the health of wheelchair users: a systematic review in multiple sclerosis, cerebral palsy, and spinal cord injury
2015     Health Quality Ontario (HQO) Physical activity counselling: a rapid review
2009     Institute for Clinical Effectiveness and Health Policy (IECS) Physical activity for the treatment of morbid obesity
2009     University of York Physical health monitoring for people with schizophrenia or other serious mental illness
2015     HAYES, Inc. Physical therapy for chronic pelvic pain
2012     Agency for Healthcare Research and Quality (AHRQ) Physical therapy interventions for knee pain secondary to osteoarthritis
2003     VA Technology Assessment Program (VATAP) Physician and nurse staffing in spinal cord injury care: relation to outcomes